Package Leaflets (PL) for Human medicinal products

The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.

The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.

The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Product Information Leaflets 121 - 150 of 255
<  Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >
SPC	Status for supply	Name of the medicinal product
		European Medicines Agency's website: Rinvoq - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Risedronat Sandoz 35 mg tabletti PL 2019-09-16
SPC	Resepti	Rismyl 0,5 mg, 1 mg, 2 mg tabletti, kalvopäällysteinen PL 2023-10-09
SPC	Resepti	Risperdal 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg tabletti, kalvopäällysteinen PL 2022-03-14
SPC	Resepti	Risperdal 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg tabletti, kalvopäällysteinen PL 2022-03-14
SPC	Resepti	Risperdal 1 mg-ml oraaliliuos PL 2022-03-14
SPC	Resepti	Risperdal Consta 25 mg, 37.5 mg, 50 mg injektiokuiva-aine ja liuotin, depotsuspensiota varten PL 2021-11-11
SPC	Resepti	Risperidon Actavis 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg tabletti PL 2018-08-03
SPC	Resepti	Risperidon Krka 0.5 mg, 1 mg, 2 mg tabletti, suussa hajoava PL 2023-03-28
SPC	Resepti	Risperidon Krka 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg tabletti, kalvopäällysteinen PL 2023-02-16
SPC	Resepti	Risperidon Krka 6 mg tabletti, kalvopäällysteinen PL 2023-02-16
SPC	Resepti	Risperidon Orion 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg tabletti, kalvopäällysteinen PL 2024-06-25
SPC	Resepti	Risperidon Orion 1 mg-ml oraaliliuos PL 2024-03-14
SPC	Resepti	Risperidon Ratiopharm 0,25 mg kalvopäällysteiset tabletit, PL 2021-10-18.doc
SPC	Resepti	Risperidon ratiopharm 0,25 mg tabletti PL 2019-05-15
SPC	Resepti	Risperidon Ratiopharm 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg tabletti, kalvopäällysteinen PL 2023-06-06
SPC	Resepti	Risperidon ratiopharm 25 mg, 37.5 mg, 50 mg injektiokuiva-aine ja liuotin, depotsuspensiota varten PL 2021-12-17
SPC	Resepti	Risperidon Sandoz 0.5 mg tabletti, kalvopäällysteinen PL 2023-10-09
SPC	Resepti	Risperidon Sandoz 1 mg tabletti, kalvopäällysteinen PL 2023-10-09
SPC	Resepti	Risperidon Sandoz 1 mg-ml oraaliliuos PL 2023-10-06
SPC	Resepti	Risperidon Sandoz 2 mg, 3 mg tabletti, kalvopäällysteinen PL 2023-10-09
SPC	Resepti	Risperidon Sandoz 4 mg tabletti, kalvopäällysteinen PL 2023-10-09
SPC	Resepti	Risperidone Grindeks 0,5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg tabletti, kalvopäällysteinen PL 2023-08-15.docx
SPC	Resepti	Risperidone Stada 0.5 mg tabletti, kalvopäällysteinen PL 2023-12-12
		European Medicines Agency's website: Ristaben - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Ristfor - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Ritonavir Accord 100 mg tabletti, kalvopäällysteinen PL 2023-05-03
SPC	Resepti	Ritonavir Sandoz 100 mg tabletti PL 2020-05-06
		European Medicines Agency's website: Ritonavir Viatris (ent. Ritonavir Mylan) - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Rivaroxaban Accord - EMA: EPAR PI Finnish Swedish
<  Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >